Fortress Biotech, Inc. (FBIOP) Other Operating Expenses (2015 - 2026)

Fortress Biotech's Other Operating Expenses history runs 11 years deep, the most recent figure standing at $6.5 million for Q4 2025.

• In Q4 2025, Other Operating Expenses rose 170.7% year-over-year to $6.5 million; the TTM figure through Dec 2025 stood at $25.2 million (up 6.28% YoY), while the FY2025 annual figure was $25.2 million, up 6.28% from the prior year.
• Other Operating Expenses for Q4 2025 stood at $6.5 million, down from $6.8 million in the prior quarter.
• The five-year high for Other Operating Expenses was $21.4 million in Q3 2021, with the low at $1.4 million in Q3 2023.
• The 5-year median for Other Operating Expenses is $6.8 million (2024), against an average of $7.9 million.
• The sharpest annual moves came in 2023 and 2024: Other Operating Expenses tumbled 80.74% in 2023, then surged 277.5% in 2024.
• Fortress Biotech's Other Operating Expenses stood at $9.5 million in 2021, then declined by 12.37% to $8.3 million in 2022, then dropped by 27.57% to $6.0 million in 2023, then slumped by 60.25% to $2.4 million in 2024, then surged by 170.7% to $6.5 million in 2025.
• Business Quant data shows FBIOP's Other Operating Expenses at $6.5 million in Q4 2025, $6.8 million in Q3 2025, and $6.0 million in Q2 2025.